The expression levels of PPAR-α/γ and UCP1/2 on the slow coronary flow phenomenon; results from a case-control study.
Mahshid GhodratAhmad SeparhamErfan BanisefidNaimeh Mesri AlamdariMoloud AkbarzadehShahriar AlipourTohid YahyapoorNeda RoshanravanSamad Ghaffari BavilPublished in: Molecular biology reports (2023)
This research provided evidence about the potential role of PPAR-α, PPAR-γ, UCP1, and UCP2 as biomarkers in SCF. More investigations are suggested to assess the functions of these factors in SCF patients mechanistically.
Keyphrases
- end stage renal disease
- insulin resistance
- ejection fraction
- newly diagnosed
- poor prognosis
- chronic kidney disease
- coronary artery
- coronary artery disease
- prognostic factors
- peritoneal dialysis
- type diabetes
- heart failure
- metabolic syndrome
- skeletal muscle
- aortic stenosis
- risk assessment
- binding protein
- climate change
- aortic valve
- transcatheter aortic valve replacement